semaglutide heart health A 2025 Lancet analysis of the SELECT trial concluded that reduced major adverse cardiovascular events by 20% in adults with overweight or obesity, regardless of how much weight patients actually lost Summary of semaglutide clinical use.

Lawsuits against Novo Nordisk claim that it failed to warn users of the risk of the following side effects: Vision loss or changes Gastroparesis (stomach paralysis) Neuropathy with gastroparesis Intestinal blockage (often requiring surgery to repair) Cyclical vomiting Pancreatic cancer Necrotizing pancreatitis Gallbladder disease Blood clots Has Trulicity Harmed You

No clinic visits, no insurance hassle

Melo, L

No dosage adjustment is recommended for renal or hepatic impairment, though patients should be monitored for dehydration-related acute kidney injury during significant gastrointestinal adverse effects

Unlike traditional weight management peptides, cagrilintide operates through the amylin receptor pathway, offering a complementary mechanism to the more widely known incretin-based therapies

Liposomal glutathione as a promising candidate for immunological rheumatoid arthritis therapy